Elsevier and Russian Foundation for Basic Research Announce SciVal | Scopus Award Russia 2012 Winners
MOSCOW, October 8, 2012 /PRNewswire/ --
Elsevier, the world-leading provider of scientific, technical, and medical information products and services, and the Russian Foundation for Basic Research (RFBR) announced the winners of the 2012 SciVal | Scopus Awards Russia.
The Scopus Awards, started in Russia in 2005, have been co-hosted by Elsevier and the Russian Foundation for Basic Research for the past two years to support scientific research in Russia by recognizing outstanding Russian scientists. This initiative is supported by the Russian Ministry of Education and Science, the Russian Academy of Science, and the Russian Academy of Medical Science.
This year, the award was named SciVal | Scopus Award because the selection criteria are based on data from both SciVal Spotlight, Elsevier's analytics database, and Scopus, the world's largest abstract and citation database for peer-reviewed literature. The selection criteria consist of the number of publications and the number of citations over the last 5 years in growing competencies, drawn from SciVal Spotlight and from Scopus, as well as the level of activity in RFBR's programs and grants.
The winners in the five award categories are:
For Outstanding Contribution to Chemistry:
Dr. Alexey Khokhlov - Vice-Rector of Moscow State University, Head of Laboratory of Physical Chemistry of Polymers, Nesmeyanov Institute of Organoelement Compounds, Moscow, Russian Federation.
For Outstanding Contribution to Mathematics:
Dr. Sergey A. Nazarov - Researcher at the Institute of Problems of Mechanical Engineering and Professor, St. Petersburg State University, St. Petersburg, Russian Federation.
For Outstanding Contribution to Physics:
Nikolai V. Antonenko and Gurgen G. Adamian from the Bogoliubov Laboratory of Theoretical Physics of Joint Institute of Nuclear Research, Dubna, Russian Federation.
For Outstanding Contribution to Biology:
Dr. Mikhail A. Gladyshev and Nadezhda N. Sushchik , Olesya N. Makhutova from The Institute of Biophysics, Siberian Branch of Russian Academy of Sciences, Krasnoyarsk, Russian Federation.
For Outstanding Contribution to Medicine (in cooperation with the Russian Academy of Medical Sciences:
Dr. Alexander M. Dygai and Dr. Gleb N. Zyuz 'kov from Tomsk Institute of Pharmacology, Siberian Branch of Russian Academy of Medical Sciences, Tomsk, Russian Federation; and Dr. Svetlana G. Vorsanova , Dr. Yuri B. Yurov and Dr. Ivan Yu . Yurov from the Mental Health Research Center, Russian Academy of Medical Sciences, Moscow, Russian Federation.
"The results of 2011 showed us how effective the interaction between the global leader Elsevier and RFBR can be, said Mr. Vladimir Eliseev , Director of Russian Foundation for Basic Research.
"Providing our researchers with high-quality scientific information is an important factor in turning Russia into a dynamic, high-tech, innovative society. Therefore, we expect and rely on the stable, long-term and mutually beneficial cooperation with Elsevier. With new Elsevier solutions we can distinguish the talented and most promising Russian scientists, who work at the front edge of world science and we are glad to present this award in collaboration with Elsevier."
YS Chi, Chairman of Elsevier, remarked, "Elsevier is honored to continue the tradition of recognizing the important achievements of Russian researchers. We are a committed partner to Russia, and we aim to help researchers grow and flourish by providing the highest quality content and innovative solutions as possible. The discoveries made by these talented individuals reflect the bright future of Russian science, and we are proud to support them."
This year's Award Ceremony was preceded by the International Congress entitled "The Ways of Russia's Development: from Fundamental Research to Innovation Technologies." Speakers included Mikhail Alfimov (Chairman of ROSNANO Board on Science and Technologies, Director of Center of Photochemistry), Y.S. Chi (Chairman, Elsevier), Dr. Kevin Downing (Chair of the QS-MAPLE International Advisory Committee and Director Knowledge, Enterprise and Analysis, City University of Hong Kong), Dr. Martin Gitsels (Head of Corporate Research & Technology and Vice-President of SIEMENS LLC) and other specialists in science and education.
# # #
About the Russian Foundation for Basic Research
The Russian Foundation for Basic Research is a self-governing foundation existing in the form of a federal institution run under the jurisdiction of the government of the Russian Federation. Its main goal is to provide support and assistance to research work in all areas of fundamental science on a competitive basis and which is called upon to build new relationships between scientists and the state. The foundation distributes federal funding to the most advanced research projects originating both from Russian universities as well as from institutions of the Russian Academy of Sciences. The RFBR is part of G8 scientific foundations family and enjoys close cooperation ties with all key funding bodies across the globe: from North America to EU, China and Japan. Financing refereed projects across disciplines, key attention is given to physics, technology and nano-technology, medicine, various interdisciplinary studies, which Russian government identified as priority in R&D development until 2020.
Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 18,000 titles from more than 5,000 international publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit http://www.info.scopus.com.
In October 2008, the Organization for Economic Co-Operation and Development (OECD) announced it would use Scopus Custom Data for its research, analysis and benchmarking work due to its broad international coverage, clean flexible data and advanced features. Australian Research Council (ARC) selected Scopus to provide citation information for the Excellence in Research for Australia (ERA) initiative Cluster One evaluation. Of the top fifty universities, as ranked by Time Higher Education (THE) World University Rankings, 50% depend on Scopus and the percentage continues to increase each year.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
More by this Source
Elsevier Announces Revamped Mosby's Index
May 09, 2013, 05:11 ET
The Elsevier Foundation Calls for 2013 New Scholars and Innovative Libraries Projects
May 06, 2013, 06:47 ET
PharmaPendium® Adds New Module to Aid Decision Making on Drug Candidates
May 06, 2013, 05:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.